Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

16.70
Delayed Data
As of Jul 21
 -0.14 / -0.83%
Today’s Change
13.41
Today|||52-Week Range
19.62
+20.75%
Year-to-Date
No recent news for Lexicon Pharmaceuticals Inc.

Today’s Trading

Previous close16.84
Today’s open16.98
Day’s range16.48 - 17.29
Volume705,264
Average volume (3 months)785,621
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)-3.91%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book11.06

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-1.50-3.05%
CBMCambrex Corp+0.05+0.08%
TBPHTheravance Biopharma...-1.41-3.73%
RGENRepligen Corp+0.28+0.66%
Data as of 4:02pm ET, 07/21/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts